We Will Miss Antibiotics When They're Gone - The New York Times - 0 views
-
more than 23,000 people in the United States are estimated to die every year from resistant bacteria.
-
Yet few new antibiotics are in development. Most large drug companies have fled the field. The reason is simple: To conserve their effectiveness, new antibiotics are put on the shelf to be used only when older antibiotics stop working. That makes perfect sense for public health, but companies can’t make a profit on what they can’t sell.
